Asian stocks began the week on a mostly positive note after earnings and Chinese economic data eased concerns about a slowdown in global growth, leaving the region’s shares on course for a fresh six-month high.
Chinese and Japanese shares posted the largest gains Monday, with equities in Hong Kong and South Korea also higher. Bullish sentiment spilled into Asia after the S&P 500 Index on Friday climbed to within 1 percent of reaching a new all-time high. Australian bonds fell, tracking the drop in Treasuries prior to the weekend. The dollar steadied with Treasuries and oil started the week with a modest decline.
Nikkei +1.40% Hang Seng +0.50% CSI +1.07% Shanghai +1.01% Shenzen +0.57%
Eur$ 1.1307 CNH 6.7098 CNY 6.7083 JPY 111.92 GBP 1.3090 RUB 64.3005 CHF 1.0018 TRY 5.7961
S&P -0.06% EuroStoxx +0.18% FTSE +0.24% Dax +0.14% SMI +0.27%
Macro :
- ECB Policymaker Sees No Need for Tiered Rates to Help Banks
- Morgan Stanley Sees Two Big Reasons Low Volatility Won’t Last
- ECB's Draghi: the key message of the IMF meeting is that there will be a significant growth slowdown this year
- Russia Fin Min Siluanov: oil prices could drop below $40/bbl for up to a year if OPEC+ partners stops curtailing their output
- Treasury Sec Mnuchin: imbalances must be addressed across Europe; US wants to address trade imbalances
- Macron’s Group Has 22.5% EU Voting Intentions: Harris Poll
- KKR Declares Japan Its ‘Highest Priority’ Outside U.S.: FT
Keep an eye on :
- AIR FP : Boeing Gets $14.3b Defense Dept. Contract for B-1/B-52 Systems
- AIR FFP : EU seeks tariff retaliation for US Boeing subsidies
- AAPL US : Huawei Is ‘Open’ to Selling 5G Chips to Apple for iPhones: CNBC
- BALN SW : Baloise Buys Belgian Insurer Fidea From Anbang for EU480 Mln
- BARC LN : Glass Lewis Urges Barclays Holders to Vote Against Bramson
- BRKN SW : Burkhalter Cuts 2018 Dividend to CHF3.90 From CHF5.00
- B5A GY : Bauer Sees 2019 Ebit About EU95 Mln, Bauer Sees 2019 Revenue About EU1.7b, Ahead of Estimate
- BRW LN : Brewin Dolphin in Talks to Buy Investec Irish Wealth Mgmt Unit
- CBG GY : Most Deutsche Bank Staff Against Commerzbank Deal: Sueddeutsche
- CHERB SS : Cherry to Delist Class B Shares From Nasdaq Stockholm
- CLASB SS : Clas Ohlson March Sales SEK605 Mln
- CLVS US : Clovis Ends Metastatic Bladder Cancer Trial for Rucaparib
- DAI GY : Daimler Cooperating With Authorities on Cheating Allegations
- DBK GY : Regulators Call on Deutsche Bank to Further Shrink U.S. Unit: FT
- EDF FP : Macron Set to Back EDF Nuclear Ops Renationalization: Parisien
- ENEL IM : Enel Mulling Bid for Sempra’s Chile and Peru Assets: Marketwatch
- GALP PL : Galp 1Q Average Net Entitlement Production 110.8 Kboepd
- GALP PL : Galp Shareholders Name CEO Gomes da Silva For New 4-Year Term
- PRTC LN : Gelesis Gets FDA Clearance to Market Plenity
- GNFT FP : Genfit to Present Positive Data From Elafibranor Trial
- GLEN LN : Aeris Unable to Come to Agreement With Glencore on CSA Mine
= IMPN SW : *IMPLENIA CEO SAYS SMALL, BOLT-ON M&A IS POSSIBLE, FUW REPORTS
- MS IM : Mediaset, Sky Italia in New R2 Accord as Watchdog Nod Unlikely
- ML FP : Michelin Sets IDR843/Share Tender Offer Price for Multistrada
- NOKIA FH : Belgium Says It Found No Proof of Spying From Huawei: Standaard
- OHL SM : OHL to Sell Canelejas Complex in Madrid: Expansion
- PUB FP : Publicis First Quarter Revenue EU2.12 Bln
- PUB FP : Publicis to Buy Alliance Data’s Epsilon for $4.4b Cash
- RDSA NA : Reliance Industries, Shell May Exit Panna-Mukta Oilfields: ET
- STRN BA : Stern Gets Unsolicited Offer, Sees Insufficient Ground to Engage
- QIA GY : *FDA ALSO APPROVES QIAGEN'S COMPANION DIAGNOSTIC WITH J&J DRUG
- VIV FP : Vivendi First Quarter Revenue EU3.46b, Est. EU3.38b, Vivendi Posts Quarterly Sales Gain on Buoyant Music Market
- VOW3 GY : VW Unveils Apple-Skinned SUV Challenger to Tesla’s Model X
- VOW3 GY : Volkswagen Says China Demand Picked up in April on VAT Cut
- VOW3 GY : Volkswagen CEO Plots Major China Push as Trouble Looms at Home
- WTB LN : Whitbread Is Expected to Cut Over 100 Head-Office Jobs: Times
- WKL NA : Applied Therapeutics Files IPO